Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Post by marrcooooon Sep 01, 2020 4:10pm
287 Views
Post# 31488433

Just a reminder of what PMED has going on:

Just a reminder of what PMED has going on:
Launch of COVID-19 test study with Max Healthcare, part of a multibillion-dollar healthcare conglomerate
Launch of Mental Illness study with Max Healthcare in collaboration with Dr. Banerji, one of Asia Pacific's foremost neurologists.
Pilots currently underway in Canadian and US hospitals including one in New York.
Sales agreements signed with:
1. Juiceworks Exhibits, whose clients include Fortune 500 companies and the world's best-known brands.
2. Caribbean Digital Media Academy technology integrator for corporations and government.
3. Taurus Medical who manufacture and market over 1,500 products for the diagnosis, treatment and monitoring of respiratory conditions in the UK.
Incorporation of Predictmedix solutions within the tech suite to be offered by Tech Mahindra, a multibillion revenue conglomerate ranked among the world's top 15 IT companies in over 90 countries with over 125,000 employees. All these guys do is tech.
Largest clinical Impairment study completed at Hindalco (40,000 employees with parent company Aditya Birla) with results to be published in scientific peer reviewed journals which giving validity to the data so it can be used in North American courts.
Appointment of Mr. Kapil Raval, Director of AI, Business Development Microsoft, as chair our advisory board and to assist with business development
Appointment of Mr. Prabhakar Srivastava, senior healthcare executive who has worked with some of the largest global healthcare conglomerates and has been an advisor to governments of African and Asian countries, will play a key role in business development for those regions.
Acquisition of Mobile Wellbeing Remote Patient Monitoring Telehealth Platform.
Filing of two patents for Remote Patient Monitoring Telehealth Platform in addition to the two patents for COVID-19 and Impairment detection screening.
It's just a matter of time before things happen and we see results.
Hopefully we get those revenue projections and metrics soon.
Also remember Q2 coming out on or before September 30 where we can see what's been going on to July 31, 2020.

<< Previous
Bullboard Posts
Next >>